European Archives - Page 912 of 1020 - European Medical Journal

EMJ

Delivering the promise of immunotherapy for melanoma

At the European Society for Medical Oncology (ESMO) Asia 2015 Congress, held in Singapore from 18 December to 21 December 2015, Peter Hersey, MD, PhD…

EMJ

Heart Attack Study Demonstrates Ex-stent of Safety in Multiple Artery Procedures

MULTIPLE artery procedures have been deemed a safe possibility for operations on heart attack patients. Treating more than one artery during cardiac…

EMJ

Meditate on This Way to Reduce Your Blood Pressure

RELAXING the mind and body through transcendental meditation (TM) could help to improve cardiovascular health, according to a recent study.

How I Treat: Multiple Sclerosis

Multiple sclerosis (MS) is a neurological disorder, characterised by inflammation and neurodegeneration.

Do the Guidelines in Oncology Need to Evolve?

Therapeutic guidelines in oncology, such as those from the National Comprehensive Cancer Network (NCCN) or the European Society for Medical Oncology…

Diagnosis and Treatment of Bladder Cancer: From Established Paradigms to Recent Advances and New Perspectives

Bladder cancer (BC) certainly represents a challenging disease for the patient, given the significant impact on health-related quality of life, and for…

GreenLight™ Laser System for Day-Case Surgery

In light of recent economic challenges, reductions in healthcare spending are vital to sustain the level of care in health services across the world.

New Insights in Nocturnal Enuresis: Going Digital, Sleep, and Genetics

Prof Tekgül opened this symposium on nocturnal enuresis (NE). Prof Bogaert described new digital initiatives for engaging with children, parents, and…

Editor’s Pick: Complement Pathway Associated Glomerulopathies

The complement system causes kidney injury in a variety of different diseases, and clinical evaluation of the complement system is an important part of…

Hormonal Therapies for Patients with Advanced Prostate Cancer

Prostate cancer (PCa) is the second most common cancer in men, comprising 15% of new cancer cases.